Adar1 Capital Management, LLC Renovo Rx, Inc. Transaction History
Adar1 Capital Management, LLC
- $615 Billion
- Q3 2024
A detailed history of Adar1 Capital Management, LLC transactions in Renovo Rx, Inc. stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 315,192 shares of RNXT stock, worth $406,597. This represents 0.05% of its overall portfolio holdings.
Number of Shares
315,192
Previous 355,240
11.27%
Holding current value
$406,597
Previous $401 Million
16.77%
% of portfolio
0.05%
Previous 0.08%
Shares
2 transactions
Others Institutions Holding RNXT
# of Institutions
16Shares Held
2.87MCall Options Held
0Put Options Held
0-
Bank Of The West975KShares$1.26 Million0.27% of portfolio
-
Bank Of Montreal Toronto, A6975KShares$1.26 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA233KShares$300,4880.0% of portfolio
-
Nixon Peabody Trust CO Boston, MA97.2KShares$125,3420.01% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny82.4KShares$106,2350.0% of portfolio
About RenovoRx, Inc.
- Ticker RNXT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 9,066,860
- Market Cap $11.7M
- Description
- RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. Its lead product candidate is RenovoGem, a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. RenovoRx, In...